◼ Archived
Health
🔮 fades ✓
Novel Injectable Drug Cuts Visceral Fat in Phase 2 Trial
Injectable CBL‑514 slashes visceral fat in a Phase 2 trial, sparking fresh debate on non‑surgical obesity solutions.
Phase 2
2 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Phase 2
This hub groups 2 separate news trends connected to Phase 2, spanning September 8, 2026 through October 2, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 12 article observations and 11 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
Roivant’s $14M bet on Bayer’s inhaled hypertension med pays off with phase 2 win
Roivant's experimental lung disease drug meets phase 2 goals